Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Altimmune Inc (NQ: ALT )

13.34 USD +0.26 (+1.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 11, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 687,257
Open 12.20
Bid (Size) 13.15 (19)
Ask (Size) 13.75 (10)
Prev. Close 13.08
Today's Range 12.20 - 13.36
52wk Range 3.050 - 35.10
Shares Outstanding 37,150,376
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Altimmune to Announce First Quarter 2021 Financial Results on May 17, 2021
From GlobeNewswire News Releases
Altimmune Announces New Preclinical Data for AdCOVID™ Demonstrating Sterilizing Immunity After a Single Intranasal Dose
From GlobeNewswire News Releases

Performance

YTD
+4.96%
+4.96%
1 Month
+6.13%
+6.13%
3 Month
-38.18%
-38.18%
6 Month
+42.98%
+42.98%
1 Year
+323.49%
+323.49%

More News

Read More
Altimmune to Present at Upcoming Scientific Conferences
From GlobeNewswire News Releases
Alternus Energy Group (ALT) Completes 9 Million (91 Million NOK) Funding, Led by Nordic ESG and Impact Investor, AV Group Sarl
From NewMediaWire
Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™
From GlobeNewswire News Releases
Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidate
From GlobeNewswire News Releases
Altimmune's Intranasal COVID-19 Vaccine Candidate Shows Sterilizing Immunity After Single Dose
Tags Market News COVID/19 Vaccine Benzinga
From Benzinga
Thinking about buying stock in Polarityte, AMC Entertainment, Altimmune, iHeartMedia, or Vale?
From PR Newswire
Add Up The Parts: JKJ Could Be Worth $0
Tags ETFs
From ETF Channel
Altimmune Clears Key Benchmark, Hitting 80-Plus RS Rating
From Investor's Business Daily
Thinking about buying stock in Nokia, BioCryst Pharmaceuticals, Beam Therapeutics, Altimmune, or Citius Pharmaceuticals?
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]